Apeiron Biotechnology is Drug Discovery in China that focus on high impact business. Founded in 2019. They cover business area such as developer, oncology drug, its automate artificial intelligence drug discovery platform, novel drug, new pathway, high impact therapeutic target, drug optimization.
2019
( 5 years old in 2024 )
High Impact
-
Room 208, Biological and Pharmaceutical Innovation Incubation Park
199 Guo Shoujing Road, Pudong New District
Shanghai
China
Private
developeroncology drugits automate artificial intelligence drug discovery platformnovel drugnew pathwayhigh impact therapeutic targetdrug optimization
* We use standard office opening hours in near Apeiron Biotechnology's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Apeiron Biotechnology is Drug Discovery business from China that founded in 2019 (5 years old in 2024), Apeiron Biotechnology business is focusing on High Impact.
Apeiron Biotechnology headquarter office and corporate office address is located in Room 208, Biological and Pharmaceutical Innovation Incubation Park 199 Guo Shoujing Road, Pudong New District Shanghai China.
Apeiron Biotechnology was founded in China.
In 2024, Apeiron Biotechnology is currently focus on high impact sector.
Above is snippet of Google Trends for "high impact" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Apeiron Biotechnology, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
